Herniated disc treatment agent

The present invention, side effects is extremely low, long-lasting and pain improvement in only one administration is obtained, which provides an intervertebral disc hernia repair agent exhibiting a high therapeutic effect and safety in clinical. The present invention is a chondroitinase ABC as an active ingredient, characterized in that it is used as the component is 1-8 units administered per disc into the disc of human concerns herniated discs therapeutic agent.